Is Hoth Therapeutics, Inc. HOTH stock halal to invest in?

No, as of February 2026, Hoth Therapeutics, Inc. stock (HOTH) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Hoth Therapeutics, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Hoth Therapeutics, Inc. and alternative halal stock options within the Tabadulat app.

How often is Hoth Therapeutics, Inc. HOTH reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Hoth Therapeutics, Inc. HOTH monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Hoth Therapeutics, Inc. HOTH pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Hoth Therapeutics, Inc. stock (HOTH) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Hoth Therapeutics, Inc. HOTH pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Hoth Therapeutics, Inc. stock (HOTH) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Hoth Therapeutics, Inc. stock (HOTH) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Hoth Therapeutics, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

HOTH

About

Hoth Therapeutics, Inc.

HOTH

Hoth Therapeutics Inc. is a biopharmaceutical company engaged in the development of new therapies for dermatological and other conditions. The company's primary focus is on creating effective treatments for skin diseases and disorders, utilizing advanced research to target unmet medical needs. Hoth Therapeutics collaborates extensively with various medical research institutions, aiming to leverage innovative biotechnology and drug development techniques to meet healthcare demands. The company's pipeline includes topical applications and drugs addressing conditions such as eczema, psoriasis, and skin infections, potentially impacting both the dermatology and broader pharmaceutical sectors. Headquartered in New York, Hoth Therapeutics also explores partnerships to enhance the development and commercialization of its products, positioning itself as a key player in the niche medical fields it targets. Through its innovative approaches and commitment to healthcare solutions, Hoth Therapeutics Inc. contributes significantly to advancements in the biopharma market.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

Website:

https://hoththerapeutics.com

HOTH

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Hoth Therapeutics, Inc.

About

Hoth Therapeutics, Inc.

HOTH

Frequently asked questions

Is Hoth Therapeutics, Inc. HOTH stock halal to invest in?

How often is Hoth Therapeutics, Inc. HOTH reviewed for Shariah compliance?

Does Hoth Therapeutics, Inc. HOTH pass the AAOIFI Non Permissible Income criteria?

Does Hoth Therapeutics, Inc. HOTH pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Hoth Therapeutics, Inc. HOTH stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.